| Outcome or subgroup title                                     | No. of studies | No. of participants | Statistical method                  | Effect size                 |
| :------------------------------------------------------------ | :------------- | :------------------ | :---------------------------------- | :-------------------------- |
| 12 Borg Scores for dyspnoea                                   | 2              |                     | Mean Difference (IV, Fixed, 95% CI) | Subtotals only              |
| 12.1 pre-six minute walk test                                 | 2              | 464                 | Mean Difference (IV, Fixed, 95% CI) | Not estimable               |
| 12.2 post-six minute walk test                                | 2              | 464                 | Mean Difference (IV, Fixed, 95% CI) | Not estimable               |
| 12.3 Post minus pre six-minute walk test                      | 2              | 472                 | Mean Difference (IV, Fixed, 95% CI) | -0.04 [-0.29, 0.20]         |
| 18 Increase in CRQ > or equal to 10 units                     | 2              | 467                 | Peto Odds Ratio (Peto, Fixed, 95% CI) | 0.77 [0.54, 1.11]           |
| 19 Number experiencing one or more COPD exacerbation          | 2              | 538                 | Peto Odds Ratio (Peto, Fixed, 95% CI) | 1.23 [0.84, 1.80]           |
| 22 Withdrawals due to adverse events                          | 4              | 1365                | Peto Odds Ratio (Peto, Fixed, 95% CI) | 1.44 [0.82, 2.52]           |
| 23 Withdrawals due to lack of efficacy                        | 4              | 1365                | Peto Odds Ratio (Peto, Fixed, 95% CI) | 1.04 [0.61, 1.79]           |
| 24 Change in peak expiratory flow (PEF)                       | 2              |                     | Mean Difference (IV, Fixed, 95% CI) | Subtotals only              |
| 24.1 Morning                                                  | 2              | 535                 | Mean Difference (IV, Fixed, 95% CI) | -10.96 [-16.09, -5.83]      |
| 24.2 Evening                                                  | 2              | 530                 | Mean Difference (IV, Fixed, 95% CI) | 2.77 [-2.59, 8.14]          |
| 25 Increased blood pressure                                   | 1              |                     | Odds Ratio (M-H, Fixed, 95% CI) | Totals not selected         |
| 26 Participants with any adverse event                        | 4              | 1365                | Peto Odds Ratio (Peto, Fixed, 95% CI) | 1.00 [0.81, 1.25]           |

## Comparison 2. Ipratropium bromide versus formoterol

| Outcome or subgroup title                                  | No. of studies | No. of participants | Statistical method                  | Effect size         |
| :--------------------------------------------------------- | :------------- | :------------------ | :---------------------------------- | :------------------ |
| 1 Absolute pre-dose FEV1 at week 12                        | 1              |                     | Mean Difference (IV, Fixed, 95% CI) | Totals not selected |
| 1.1 formoterol 12mcg                                       | 1              |                     | Mean Difference (IV, Fixed, 95% CI) | Not estimable       |
| 1.2 formotrol 24mcg                                        | 1              |                     | Mean Difference (IV, Fixed, 95% CI) | Not estimable       |
| 2 Rescue bronchodilator use: number of daytime puffs       | 1              |                     | Mean Difference (IV, Fixed, 95% CI) | Subtotals only      |
| 2.1 ipratropium versus 12mcg formoterol                    | 1              | 359                 | Mean Difference (IV, Fixed, 95% CI) | Not estimable       |
| 2.2 ipratropium versus 24mcg formoterol                    | 1              | 347                 | Mean Difference (IV, Fixed, 95% CI) | Not estimable       |
| 3 Change in FEV1(% predicted) from baseline after 3 months | 1              |                     | Mean Difference (IV, Fixed, 95% CI) | Totals not selected |
| 4 Change in FVC (% predicted) from baseline after 3 months | 1              |                     | Mean Difference (IV, Fixed, 95% CI) | Totals not selected |
| 5 Change in St Georges Respiratory Questionnaire HRQL (% max score) | 1              |                     | Mean Difference (IV, Fixed, 95% CI) | Not estimable       |
| 5.1 Total                                                  | 1              |                     | Mean Difference (IV, Fixed, 95% CI) | Not estimable       |
| 5.2 Symptoms                                               | 1              |                     | Mean Difference (IV, Fixed, 95% CI) | Not estimable       |
| 5.3 Activity                                               | 1              |                     | Mean Difference (IV, Fixed, 95% CI) | Not estimable       |
| 5.4 Impacts                                                | 1              |                     | Mean Difference (IV, Fixed, 95% CI) | Totals not selected |
| 6 Shuttle Walk Test Distance change from baseline          | 1              |                     | Mean Difference (IV, Fixed, 95% CI) | Subtotals only      |
| 7 Symptom scores (change from baseline)                    | 1              | 123                 | Mean Difference (IV, Fixed, 95% CI) | 0.18 [-0.01, 0.37]  |
| 7.1 Breathlessness -night                                  | 1              | 123                 | Mean Difference (IV, Fixed, 95% CI) | -0.08 [-0.24, 0.08] |
| 7.2 Breathlessness -daytime                                | 1              | 123                 | Mean Difference (IV, Fixed, 95% CI) | 0.13 [-0.04, 0.30]  |
| 7.3 Cough -night                                           | 1              | 123                 | Mean Difference (IV, Fixed, 95% CI) | -0.08 [-0.27, 0.11] |
| 7.4 Cough- daytime                                         | 1              | 123                 | Mean Difference (IV, Fixed, 95% CI) | 0.15 [-0.02, 0.32]  |
| 7.5 Sleep                                                  | 1              | 123                 | Mean Difference (IV, Fixed, 95% CI) | Totals not selected |
| 8 Absolute SGRQ scores at week 12-formoterol 12mcg         | 1              |                     | Mean Difference (IV, Fixed, 95% CI) | Not estimable       |
| 8.1 Total                                                  | 1              |                     | Mean Difference (IV, Fixed, 95% CI) | Not estimable       |
| 8.2 Symptoms                                               | 1              |                     | Mean Difference (IV, Fixed, 95% CI) | Not estimable       |
| 8.3 Activity                                               | 1              |                     | Mean Difference (IV, Fixed, 95% CI) | Not estimable       |
| 8.4 Impacts                                                | 1              |                     | Mean Difference (IV, Fixed, 95% CI) | Totals not selected |
| 9 Absolute SGRQ scores at week 12-formoterol 24mcg         | 1              |                     | Mean Difference (IV, Fixed, 95% CI) | Not estimable       |
| 9.1 Total                                                  | 1              |                     | Mean Difference (IV, Fixed, 95% CI) | Not estimable       |
| 9.2 Symptoms                                               | 1              |                     | Mean Difference (IV, Fixed, 95% CI) | Not estimable       |
| 9.3 Activity                                               | 1              |                     | Mean Difference (IV, Fixed, 95% CI) | Not estimable       |
| 9.4 Impacts                                                | 1              |                     | Mean Difference (IV, Fixed, 95% CI) | Not estimable       |
<PAGE>97